Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Cell Reports
|
June 27, 2024
Both enantiomers of β-aminoisobutyric acid BAIBA regulate Fgf23 via MRGPRD receptor by activating distinct signaling pathways in osteocytes
Eijiro Sakamoto, Yukiko Kitase, Alexander J Fitt, et al.
The Journal of Clinical Investigation
|
August 22, 2007
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa, Erik A Imel, Mary L Kreiter, et al.
Endocrinology
|
August 6, 2005
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23
Xijie Yu, Omar A Ibrahimi, Regina Goetz, et al.
Endocrinology
|
March 22, 2017
Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels
Vanessa M Knab, Braden Corbin, Olena Andrukhova, et al.
Kidney International
|
September 19, 2008
A rat model of chronic kidney disease-mineral bone disorder
Sharon M Moe, Neal X Chen, Mark F Seifert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S Tagliabracci, James L Engel, Sandra E Wiley, et al.
The American Journal of Pathology
|
January 31, 2025
Klotho Is Cardioprotective in the mdx Mouse Model of Duchenne Muscular Dystrophy
Areli Jannes S Javier, Felicia M Kennedy, Xin Yi, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 7, 2008
Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis
Holly J Garringer, Mahdi Malekpour, Fatemehsadat Esteghamat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 22, 2003
Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II
Steven G Waguespack, Daniel L Koller, Kenneth E White, et al.
JCI Insight
|
March 5, 2019
Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD
Erica L Clinkenbeard, Megan L Noonan, Joseph C Thomas, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Cell Reports
|
June 27, 2024
Both enantiomers of β-aminoisobutyric acid BAIBA regulate Fgf23 via MRGPRD receptor by activating distinct signaling pathways in osteocytes
Eijiro Sakamoto, Yukiko Kitase, Alexander J Fitt, et al.
The Journal of Clinical Investigation
|
August 22, 2007
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa, Erik A Imel, Mary L Kreiter, et al.
Endocrinology
|
August 6, 2005
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23
Xijie Yu, Omar A Ibrahimi, Regina Goetz, et al.
Endocrinology
|
March 22, 2017
Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels
Vanessa M Knab, Braden Corbin, Olena Andrukhova, et al.
Kidney International
|
September 19, 2008
A rat model of chronic kidney disease-mineral bone disorder
Sharon M Moe, Neal X Chen, Mark F Seifert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2014
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S Tagliabracci, James L Engel, Sandra E Wiley, et al.
The American Journal of Pathology
|
January 31, 2025
Klotho Is Cardioprotective in the mdx Mouse Model of Duchenne Muscular Dystrophy
Areli Jannes S Javier, Felicia M Kennedy, Xin Yi, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 7, 2008
Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis
Holly J Garringer, Mahdi Malekpour, Fatemehsadat Esteghamat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 22, 2003
Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II
Steven G Waguespack, Daniel L Koller, Kenneth E White, et al.
JCI Insight
|
March 5, 2019
Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD
Erica L Clinkenbeard, Megan L Noonan, Joseph C Thomas, et al.
Page
of 9